Michele Yang
Neurology with Special Qualifications in Child Neurology · Aurora, CONPI 1801014501
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,115 of the $15,263 with a category attached, or 79.4%. Sarepta Therapeutics, Inc. accounts for 61.4% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $13,762, more than ten times the $1,342 reported in 2019. Among neurology with special qualifications in child neurology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 24 payments — averaging $635.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sarepta Therapeutics, Inc.$9K
- PTC Therapeutics, Inc.$4K
- NS Pharma, Inc.$1K
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$61
- Novartis$60
- Astellas Pharma US Inc$37
- plus $13 from 1 others
Across 32 payments — averaging $13,212 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- NS Pharma, Inc.$286K
- Janssen Research & Development, LLC$96K
- Sarepta Therapeutics, Inc.$40K
What the payments were for
- Consulting fees$12,11579%
- Speaking & faculty fees$600%
- Travel & lodging$2,05813%
- Food & beverage$1,0177%
- Education$130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sarepta Therapeutics, Inc. | 7 | $9,374 |
| PTC Therapeutics, Inc. | 11 | $4,376 |
| NS Pharma, Inc. | 2 | $1,342 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 1 | $61 |
| Novartis | 1 | $60 |
| Astellas Pharma US Inc | 1 | $37 |
| Catalyst Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Elevidys$9,115
- Viltolarsen (NS-065/NCNP-01)$1,342
How this compares
$15,263 in reported general payments places this provider in the 95th percentile of 41 neurology with special qualifications in child neurology providers in Colorado.
See all neurology with special qualifications in child neurology providers in Colorado →
Other neurology with special qualifications in child neurology in Aurora
- Julie ParsonsAurora$178K
- Timothy BenkeAurora$9K
- Ryan KammeyerAurora$4K
- Teri SchreinerAurora$3K
- Marcy YonkerAurora$3K
- Jessica LitwinAurora$2K
- Jennifer ArmstrongAurora$2K
- Abigail CollinsAurora$2K
- Jennifer JaskiewiczAurora$937
- Benjamin RossAurora$803
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.